GI Stool Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The market is segmented By Product Type (Instrument and Reagent), Test Type (Occult Blood Test, Ova & Parasites Test, Bacteria Test, Fecal Biomarkers Test, and Other Test Types), and Geography.

Market Snapshot

Market Snapshot
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The increasing burden of diseases related to the gastrointestinal tract and rising demand for point of care tests is expected to fuel the GI stool testing market growth. According to the World Health Organization, diarrhea is considered the second leading cause of death in children under five years of age, and around 1.7 billion cases are recorded every year. Furthermore, there is a rising prevalence of colorectal cancer across the globe, which is expected to boost the overall growth of the market over the forecast period. Thus, this factor can increase the demand for GI stool testing to detect bacteria and parasites.

Scope of the Report

The GI stool testing involves the detection and analysis of any pathogens in the digestive tract using the stool as a sample. The market is segmented By Product Type, Test Type, and Geography.

By Product Type
By Test Type
Occult Blood Test
Ova and Parasites Test
Bacteria Test
Fecal Biomarkers Test
Other Test Types
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Reagent Segment is Expected to Hold a Major Market Share in the GI Stool Testing Market

  • Reagents are substances that are often used for examining and analyzing. Reagents are expected to dominate the GI stool testing market with developing diagnostic technology. Chemiluminant assays are used as a diagnostic aid for the detection of gastrointestinal infections. It uses enzyme-labeled antibodies for detection, which is known to give an accurate diagnosis. According to the study published by the Journal of Investigative Medicine, in 2016, laboratory-based chemiluminescent assays were used for detection H. Pylori. The sensitivity and specificity of this assay were found out to be approximately 90.1% and 92.4%.
  • Furthermore, the rising prevalence of diarrhea is expected to raise the demand for reagents in the GI stool testing market. According to the World Health Organization, in the European region, 14 people die because of diarrhoeal disease. Hence, it is expected to influence the GI stool testing market growth positively in this segment.
GI stool testing Market Trend Image.png

North America is Expected to Hold a Significant Share in the Market and is Expected to Witness the Same in the Forecast Period

Increasing the geriatric population and higher incidence rate of gastrointestinal diseases such as colorectal cancer is expected to influence the GI stool testing market in North America positively. According to the study published in 2019, by the Canadian Journal of Gastroenterology and Hepatology, gastrointestinal infections frequently occur in the geriatric population. Furthermore, H.pylori infection is largely diagnosed in the elderly group. According to the Centre for Disease Control and Prevention, approximately 14,795 people were diagnosed with an ulcer in the United States. Ulcers are usually found in the lining of the stomach. H. Pylori is the main cause of these ulcers, and for its detection, usually, stool testing is performed. According to the United States Census Bureau, the population aged between 65 and 74 was found to be around 30.58 million.

Furthermore, according to the American Cancer Society, around 140,250 were diagnosed with colorectal cancer in the United States. For the diagnosis of colorectal cancer, a fecal occult blood test is performed. Thus, these factors are expected to fuel the GI stool testing market growth.

GI Stool Testing Market - Growth rate by Region

Competitive Landscape

Collaborations, mergers, and acquisitions by companies related to GI stool testing are expected to boost the market growth. In 2016, Abbott Laboratories acquired Alere, Inc. to extend its diagnostics product line. Some of the companies which are currently dominating the GI stool testing market are bioMérieux SA, DiaSorin S.p.A, Cenogenics Corporation, Abbott Laboratories, Epitope Diagnostics Inc., Genova Diagnostics, Beckman Coulter, Inc., ScheBo Biotech AG, CTKBiotech Inc. Inc., and Cardinal Health.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Gastrointestinal Diseases

      2. 4.2.2 Rising Preference of Point of Care Test

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Instruments

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Instruments

      2. 5.1.2 Reagents

    2. 5.2 By Test Type

      1. 5.2.1 Occult Blood Test

      2. 5.2.2 Ova and Parasites Test

      3. 5.2.3 Bacteria Test

      4. 5.2.4 Fecal Biomarkers Test

      5. 5.2.5 Other Test Types

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Beckman Coulter Inc.

      3. 6.1.3 bioMerieux SA

      4. 6.1.4 Cardinal Health

      5. 6.1.5 Cenogenics Corporation

      6. 6.1.6 CTK Biotech Inc.

      7. 6.1.7 Genova Diagnostics

      8. 6.1.8 Epitope Diagnostics Inc.

      9. 6.1.9 ScheBo Biotech AG

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The GI Stool Testing Market market is studied from 2018 - 2026.

The GI Stool Testing Market is growing at a CAGR of 7.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott Laboratories , Genova Diagnostics , bioMérieux SA , Beckman Coulter, Inc. , Cardinal Health are the major companies operating in GI Stool Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!